Patent AT-E400652-T1: [Translated] TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTORS
HealthData.Gov
Updated Oct 29, 2026
About this dataset
The invention concerns new tumor necrosis factor receptor associated factors, designated TRAFs. The new factors are capable of specific association with the intracellular domain of the type 2 TNF receptor (TNF-R2) and CD40, and are involved in the mediation of TNF and CD40 ligand biological activities.
Data and resources (1)
- HTML
Official Data Source
Access the complete Patent AT-E400652-T1: [Translated] TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTORS on the official website.
Modified Dec 27, 2025